Premium
Medicaid expansion found to promote wider use of opioid agonist therapy
Author(s) -
Enos Gary
Publication year - 2019
Publication title -
alcoholism and drug abuse weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7591
pISSN - 1042-1394
DOI - 10.1002/adaw.32430
Subject(s) - medicaid , opioid use disorder , agonist , opioid , psychiatry , medicine , family medicine , health care , political science , law , receptor
Results of a study published this month in Psychiatric Services suggest that if states want to ensure greater provision of evidence‐based care for opioid use disorder (OUD), expanding Medicaid offers an effective strategy for doing so. At the same time, the study data indicate that Medicaid expansion alone is not sufficient for making agonist therapies accessible in dramatic numbers.